Alle News

Michele Solimena

Awards & Grants, Diabetes, IPI,

Michele Solimena Honored With the 2026 Paul Langerhans Medal of the DDG

Prof. Michele Solimena received the Paul Langerhans Medal, the highest award of the German Diabetes Society (DDG), on May 15, 2026. The prize recognizes his outstanding lifetime scientific achievements in the field of diabetes research. The…

Screenshot pancreas für research area "type 1 diabetes pathology" (Teresa Rodgriguez-Calvo)

Awards & Grants, Diabetes, IDF,

New Funding Supports Research into Causes and Treatment of Type 1 Diabetes

Dr. Teresa Rodriguez-Calvo from Helmholtz Munich has been awarded two prestigious grants from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization. The funding will support two innovative projects at the…

Institut für Diabetesforschung Studienzentrum

Diabetes, IDF,

Fr1da Study Expands Early Diabetes Detection to 12 German Federal States

As part of the Fr1da study, “Early detection and early treatment of type 1 diabetes”, led by researchers at the Institute of Diabetes Research at Helmholtz Munich, families can have their children aged two to ten tested for an early stage of type 1…

“Your Start to an Active Everyday Life” on diabinfo.de – Start Moving Today

Diabetes,

New Video Series on diabinfo.de for More Exercise in Everyday Life

Regular exercise is a key component of a healthy lifestyle and is particularly important for preventing type 2 diabetes and other non-communicable diseases. Nevertheless, many people find it difficult to incorporate sufficient exercise into their…

glucagon like peptide 1 glp1 7 36 molecule the glucagon like peptide 1 receptor has a strong effect on the management of type 2 diabetes mellitus

New Research Findings, Diabetes, IDO,

One Molecule, Two Effects: A New Drug Concept to Treat Obesity and Type 2 Diabetes

A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity and type 2 diabetes: a hybrid molecule uses the well-known GLP-1/GIP signalling pathway as a “door opener” and delivers an…

Portrait Anette Gabriele Ziegler, Querformat;

Awards & Grants, Diabetes, IDF,

Anette-Gabriele Ziegler Receives Claude Bernard Prize for Diabetes Research

Prof. Anette-Gabriele Ziegler from Helmholtz Munich has been named the recipient of the 58th Claude Bernard Prize, the highest honor awarded by the European Association for the Study of Diabetes (EASD). The prize recognizes her outstanding leadership…